Key result
The proposed multi-branch joint attention network (MJANet) achieved an 85.23% accuracy rate in differentiating Alzheimer's disease from normal controls, an 8.03% improvement over the state-of-the-art.
Why the study?
Traditional EEG-based Alzheimer's disease detection methods do not fully leverage spatial information about brain activity and correlations between frequency bands, leading to suboptimal cross-patient performance.
Does a multi-branch joint attention network (MJANet) based on EEG source imaging improve the detection accuracy of Alzheimer's disease compared to state-of-the-art methods?
Does a multi-branch joint attention network (MJANet) based on EEG source imaging improve the detection accuracy of Alzheimer's disease compared to state-of-the-art methods?
Answers are grounded in this paper and cite their sources.
The proposed MJANet based on EEG source imaging improves the accuracy of detecting Alzheimer's disease and differentiating it from frontotemporal dementia and normal controls.
Objective. Alzheimer’s disease (AD) is a neurodegenerative disorder detectable via electroencephalogram (EEG). Traditional EEG-based AD detection methods do not fully leverage spatial information about brain activity and the correlation between different frequency bands, leading to suboptimal cross-patient performance. Approach. We propose a new multi-branch joint attention network (MJANet) based on electrophysiological source imaging (ESI) to create comprehensive spatial power maps, improving the spatial resolution of EEG. The MJANet incorporates a multi-branch joint attention (MBJA) mechanism to capture interactions across different frequency bands. The MJANet employs a new MBJA mechanism to capture interactions across frequency bands and a moving shifted window to capture global image features. It analyzes correlations between activities in various bands and brain regions to boost cross-patient detection capabilities. Main results. The proposed approach is validated on a public dataset with a leave-one-subject-out cross-validation strategy, achieving an 85.23% accuracy rate in differentiating AD from normal controls (NC), representing an 8.03% improvement over the state-of-the-art. Moreover, it achieves 75.57% accuracy in distinguishing frontotemporal dementia (FTD) from NC, and 63.97% for the classification of AD, NC, and FTD. We utilize GradCAM to visualize the joint attention mechanism, providing insights into its decision-making process. Significance. This work explores a novel biomarker that has the potential to enhance clinical diagnostic methods and improve diagnostic accuracy.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2025) studied Alzheimer's disease and frontotemporal dementia. Multi-branch joint attention network (MJANet) based on electrophysiological source imaging (ESI) vs. State-of-the-art methods was evaluated on Accuracy in differentiating Alzheimer's disease from normal controls. The proposed multi-branch joint attention network (MJANet) achieved an 85.23% accuracy rate in differentiating Alzheimer's disease from normal controls, an 8.03% improvement over the state-of-the-art.
Synapse has enriched 10 related papers. Consider them for comparative context: